. J Vasc Surg
Venous Lymphat Disord 2019;7:471-9.
2. Mann M, Wang P, Schul M, Khilnani NM, Park A, Makary MA, et al.
Signiﬁcant physician practice variability in the utilization of endovenous thermal ablation in the 2017 Medicare population. J Vasc
Surg Venous Lymphat Disord 2019;7:808-16.e1.
3. Stonko DP, Dun C, Walsh C, Schul M, Blebea J, Boyle EM, et al.
Evaluation of a physician peer-benchmarking intervention for
practice variability and costs for endovenous thermal ablation.
JAMA Netw Open 2021;4:e2137515.
4. Prabhakar AM, Misono AS, Sheth RA, Rosenkrantz AB,
Hemingway J, Hughes DR, et al. Changing Medicare utilization of
minimally invasive procedures for the treatment of chronic venous
insufﬁciency. J Vasc Interv Radiol 2017;28:818-24.
5. Rasmussen L, Lawaetz M, Bjoern L, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome
after 5 years. J Vasc Surg 2013;58:421-6.
6. Rass K, Frings N, Glowacki P, Graber S, Tilgen W, Vogt T. Same site
recurrence is more frequent after endovenous laser ablation
compared with high ligation and stripping of the great saphenous
vein: 5 year results of a randomized clinical trial (RELACS study). Eur
J Vasc Endovasc Surg 2015;50:648-56.
7. Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings A, Eklof B, et al.
Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins